{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-029417","form_type":"8-K","ticker":"RYTM","cik":"0001649904","company_name":"RHYTHM PHARMACEUTICALS, INC.","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.976224+00:00","generated_at":"2026-06-05T06:47:18.006606+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Rhythm Pharmaceuticals amends sales agreement to allow up to $200M in at-the-market stock offerings","bullets":["Amendment increases ATM offering limit from $100M to $200M, excluding $50M already sold.","Company had $50M in prior sales as of Feb 29, 2024; new capacity starts from zero.","No specific use of proceeds disclosed; typical for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-029417","json":"https://secwatch.observer/filing/0001104659-24-029417.json","markdown":"https://secwatch.observer/filing/0001104659-24-029417.md","text":"https://secwatch.observer/filing/0001104659-24-029417.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649904/000110465924029417/0001104659-24-029417-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649904/000110465924029417/tm247530d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T06:47:18.006606+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}